Concepedia
Statistics
Publications
7
Citations
488
H-Index
Active since
2009
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
AstraZeneca (Brazil)
AstraZeneca (Singapore)
The Gurdon Institute
Lucy A. Young is an author at AstraZeneca (United Kingdom).
Publications per year
2009–2025
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
Rebecca L. Lloyd, Paul W.G. Wijnhoven, Antonio Ramos‐Montoya et al. · Oncogene · 2020 · 179 citations · Full text
Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes
Ian Powley, Alexander Kondrashov, Lucy A. Young et al. · Genes & Development · 2009 · 142 citations · Full text
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress
Lucy A. Young, Lenka Oplustil O'Connor, Christelle de Renty et al. · Cancer Research · 2019 · 69 citations · Full text
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry
Gemma N. Jones, Claire Rooney, Nicola Griffin et al. · British Journal of Cancer · 2018 · 35 citations · Full text
Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation
Marta López‐Peláez, Lucy A. Young, Mercedes Vázquez–Chantada et al. · OncoImmunology · 2022 · 30 citations · Full text
1–5 of 7